You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

Not yet recruiting
  • Influenza, Human
  • +4 more
  • aH5N8c on Day 1
  • +4 more
  • Cullman, Alabama
  • +8 more
May 15, 2023

Influenza Trial in Baltimore (H5N1 pISV)

Completed
  • Influenza
  • H5N1 pISV
  • Baltimore, Maryland
    Center for Immunization Research, Johns Hopkins Bloomberg School
Feb 15, 2022

Influenza, Human, Influenza in Birds, Respiratory Tract Infections Trial in United States (aH5N6c on Day 1, aH5N6c on Day 22,

Recruiting
  • Influenza, Human
  • +7 more
  • aH5N6c on Day 1
  • +2 more
  • Huntsville, Alabama
  • +17 more
Jul 26, 2022

Influenza, Human Trial in Estonia, Philippines (H5N1 antigen combined with MF59 adjuvant)

Completed
  • Influenza, Human
  • H5N1 antigen combined with MF59 adjuvant
  • Tallinn, Harjumaa, Estonia
  • +6 more
Jul 21, 2022

Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose

Not yet recruiting
  • Influenza, Human
  • +4 more
  • Low dose A/H2N3c + standard dose MF59
  • +5 more
  • Rockville, Maryland
  • +7 more
May 26, 2023

Influenza, Pandemic Trial in Baltimore (BW-1014: 25 µg rH5 in 20% NE - pipette - IN, BW-1014: 50 µg rH5 in 20% NE - pipette -

Recruiting
  • Influenza, Pandemic
  • BW-1014: 25 µg rH5 in 20% NE - pipette - IN
  • +5 more
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, University of
Jul 8, 2022

Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su

Not yet recruiting
  • Respiratory Syncytial Viruses
  • RSVPreF3 OA investigational vaccine
  • HZ/su vaccine
  • Daphne, Alabama
  • +23 more
Jul 21, 2023

Pandemic Influenza Trial in United States (A/H5N1, LT Adjuvant Patch)

Completed
Has Results
  • Pandemic Influenza
  • A/H5N1
  • LT Adjuvant Patch
  • Anaheim, California
  • +5 more
Dec 9, 2021

Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT Lot 1 vaccine (GSK3888550A), RSV MAT Lot 2 vaccine

Completed
  • Respiratory Syncytial Virus Infections
  • RSV MAT Lot 1 vaccine (GSK3888550A)
  • +4 more
  • West Palm Beach, Florida
  • +35 more
Jul 14, 2022

Seasonal Influenza, Influenza, Influenza Due to Unspecified Influenza Virus Trial in Antwerpen, Hasselt (MF59C.1-adjuvanted

Completed
Has Results
  • Seasonal Influenza
  • +3 more
  • MF59C.1-adjuvanted subunit influenza vaccine
  • Sub unit, Inactivated, Influenza vaccine
  • Antwerpen, Belgium
  • +1 more
Apr 14, 2021

Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)

Active, not recruiting
  • Influenza
  • FLUAD Quadrivalent
  • FluQuadri
  • Lima, Peru
  • +1 more
Sep 19, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • 23-PPV
  • +5 more
  • Cullman, Alabama
  • +21 more
Apr 4, 2022

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Vaccination; Infection, Maternal-Fetal Relations, Pertussis Trial in Brussels (Boostrix® (Pertussis-containing vaccine), Hexyon®

Not yet recruiting
  • Vaccination; Infection
  • +3 more
  • Boostrix® (Pertussis-containing vaccine)
  • Hexyon® (Pertussis-containing vaccine)
  • Brussels, Belgium
    CHU Saint-Pierre
May 3, 2023

Pandemic Influenza Disease Trial in Tampere, München (Placebo (PL), Trivalent influenza virus vaccine (TIV), Adjuvanted

Completed
Has Results
  • Pandemic Influenza Disease
  • Placebo (PL)
  • +3 more
  • Tampere, Finland
  • +1 more
Apr 22, 2021

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • +12 more
    • Bedford, Bedfordshire, United Kingdom
    • +8 more
    Feb 22, 2022

    Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA Investigational Vaccine)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA Investigational Vaccine
    • Phoenix, Arizona
    • +52 more
    Jun 16, 2023

    HIV, H1N1 Influenza Virus Trial in Puerto Rico, United States (Influenza A (H1N1) monovalent vaccine)

    Completed
    Has Results
    • HIV Infections
    • H1N1 Influenza Virus
    • Influenza A (H1N1) monovalent vaccine
    • Alhambra, California
    • +30 more
    Nov 3, 2021

    Influenza Trial in Houston, Gießen (Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59, Cell Culture-Derived H5N1

    Completed
    • Influenza
    • Cell Culture-Derived H5N1 Subunit Influenza Vaccine, 3.75_0%MF59
    • +11 more
    • Houston, Texas
    • +1 more
    Aug 20, 2020

    HIV, H1N1 Influenza Virus Trial in Puerto Rico, United States (Influenza A (H1N1) 2009 monovalent vaccine)

    Completed
    Has Results
    • HIV Infections
    • H1N1 Influenza Virus
    • Influenza A (H1N1) 2009 monovalent vaccine
    • Birmingham, Alabama
    • +36 more
    Nov 3, 2021

    Response to Influenza Vaccination in Pediatric Oncology Patients

    Recruiting
    • Hematologic Malignancy
    • +2 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Oct 17, 2022

      Influenza, Human Trial (Fluzone Quadrivalent, Flublok Quadrivalent)

      Not yet recruiting
      • Influenza, Human
      • Fluzone Quadrivalent
      • Flublok Quadrivalent
      • (no location specified)
      Aug 22, 2022

      Influenza A Subtype H5N1 Infection Trial in Decatur (Seasonal Influenza Vaccine)

      Completed
      Has Results
      • Influenza A Subtype H5N1 Infection
      • Seasonal Influenza Vaccine
      • Decatur, Georgia
        The Hope Clinic of Emory University
      Feb 28, 2020

      Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

      Recruiting
      • Anaplastic Ependymoma
      • +14 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 17, 2022

      DLBCL Trial in Ottawa, Toronto (DPX-Survivac, Cyclophosphamide)

      Terminated
      • Diffuse Large B-Cell Lymphoma
      • Ottawa, Ontario, Canada
      • +1 more
      Jun 16, 2021